Kenji Ikeda

Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial

Masatoshi Kudo, Richard S. Finn, Shukui Qin et al. · The Lancet · 2018 · 5.4K citations · Full text

Medicine, Oncology, Pharmacology +12

TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

Tetsuaki Arai, Masato Hasegawa, Haruhiko Akiyama et al. · Biochemical and Biophysical Research Communications · 2006 · 2.8K citations

Life Sciences, Neurology, Neuroscience +11

Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma

Yujin Hoshida, Augusto Villanueva, Masahiro Kobayashi et al. · New England Journal of Medicine · 2008 · 1.3K citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Integrative Transcriptome Analysis Reveals Common Molecular Subclasses of Human Hepatocellular Carcinoma

Yujin Hoshida, Sebastian Nijman, Masahiro Kobayashi et al. · Cancer Research · 2009 · 1.2K citations · Full text

Medicine, Molecular Biology, Oncology +17

UCP1-independent signaling involving SERCA2b-mediated calcium cycling regulates beige fat thermogenesis and systemic glucose homeostasis

Kenji Ikeda, Qianqian Kang, Takeshi Yoneshiro et al. · Nature Medicine · 2017 · 660 citations

Life Sciences, Molecular Biology, Physiology +16